Oncothyreon Inc. (ONTY) was a big mover last session with its shares rising almost 16% on the day. The upside was owing to the company’s announcement that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Jefferies 2015 Healthcare Conference in New York on June 3, 2015. This development led to far more shares changing hands yesterday than in a normal session. The move continues the recent uptrend of the company as the stock has gained over 114% in the past one-month time frame.
This clinical-stage biopharmaceutical company has seen one positive estimate revision in the last 30 days. However, the Zacks Consensus Estimate has remained unchanged over the same period. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this stock in the near future.
Oncothyreon currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Investors interested in the biomedical industry may consider Actelion Ltd. (ALIOF) which sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment